The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access.
This program has been designed for Family Medicine, Pediatrics, Neurology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease
HIV Grand Rounds is supported by independent educational grants from Gilead Sciences, Inc., ViiV Healthcare, Janssen Therapeutics and Merck Sharp and Dohme Corp.
After completing this activity, participants should be better able to:
|
Ian Frank, MD
Katherine Bar, MD
Florence Momplaisir, MD, MSHP, FACP |
The Next Presentation of HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania will be:
Topic: Highlights from the International AIDS Society Conference, Brisbane 2023
Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
|
January 12, 2023 The Top Ten Publications in HIV Medicine in 2022 Ian Frank, MD January 19, 2023 Translocated microbiome composition determines immunological outcome in treated HIV infection Daniel Douek, MD January 26, 2023 Rational Vaccine Strategies against HIV and Coronaviruses Raiees Andrabi, PhD February 2, 2023 Understanding the HIV reservoir…one cell at a time Michael R. Betts, PhD February 9, 2023 Differentiated service delivery for PrEP Sara Clemens, MD March 2, 2023 Highlights from CROI 2023: Not the HIV Stuff
Ian Frank, MD March 9, 2023 Highlights from CROI 2023: The HIV Stuff
Paul Sax, MD March 16, 2023 Clinical Cases in HIV
Antonio Urbina, MD March 23, 2023 Of apps and equity: where do we stand in HIV prevention for MSM?
Patrick Sullivan, DVM, PhD, FACVPM March 30, 2023 History of Tuberculosis
Sneha Thatipelli, MD April 6, 2023 Findings from the Community PrEP Study: Leveraging community-based platforms to provide same-day PrEP initiation services and adherence support for adolescent girls and young women in South Africa
Andrew Marino-Medina, PhD April 13, 2023 COVID-19 among People with Immune Compromised Conditions: from Big Data to Clinical Epidemiology
Jing Sun, MD, MPH, PhD April 20, 2023 Seeing the unseen: Subclinical cardiomyopathy in newly diagnosed persons with HIV
Pieter-Paul S. Robbertse PhD, MBChB April 27, 2023 Fatty Liver in People with HIV
Jessie Torgersen, MD, MHS, MSCE May 4, 2023 Treatment of Drug-Resistant Pulmonary TB: Guidelines and Guidance
Gregory P. Bisson, MD, MSCE May 11, 2023 Considerations for the induction of protective B cell responses to HIV: Insights from animal models and high-risk populations
James Kobie, PhD May 18, 2023 HIV and COPD
Sarath Raju, MD, MPH May 25, 2023 Broadly neutralizing antibodies for HIV prevention and treatment
Katharine J. Bar, MD June 1, 2023 HIV Care in 2023 and Beyond
Jurgen Rockstroh, MD June 8, 2023 Weight gain with Antiretroviral Therapy: A Case-Based Approach
Todd Brown, MD, PhD June 15, 2023 Catalyzing Pediatric TB innovation (CAP TB): A Pre- and Post-Intervention Analysis
Jennifer Cohn, MD, MPH June 22, 2023 When Viruses Go Wild: How HIV and SARS-CoV-2 Can Become Unsuppressible
Jonathan Li, MD, MMSc September 7, 2023 Long Acting Small Molecule Plus bNAb Combinations for ART
Babafemi Taiwo, MBBS September 14, 2023 Highlights from the International AIDS Society Conference, Brisbane 2023
Renslow Sherer, MD TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW: |
You will need Internet to participate in this activity.
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours
PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.
It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE) have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
|
Florence Momplaisir, MD (Program Co-Director) Planning Committee Members:
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
|
Ian Frank, MD (Program Co-director)
Katherin Bar, MD (Program Co-director)
|
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
